Is India doing enough to tackle the common genetic blood disorder Thalassemia?
Is an auditing required to assess the healthcare quality in India?
Can collaboration between startups and big life sciences companies offer a disruptive breakthrough?
Is the e-pharma industry coming out as a boon?